Darusentan
id:
darusentan-256-7920758
title:
Darusentan
text:
Darusentan is an endothelin receptor antagonist. Gilead Colorado, a subsidiary of Gilead Sciences, under license from Abbott Laboratories, is developing darusentan for the potential treatment of uncontrolled hypertension. In June 2003, Myogen licensed the compound from Abbott for its application in the cancer field. In May 2007, a randomized, double-blind, active control, parallel assignment, safety and efficacy phase III trial was initiated in subjects who had completed the maintenance period o
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Darusentan
date created:
date modified:
2024-02-04T11:51:22Z
main entity:
{"identifier":"Q5225810","url":"https://www.wikidata.org/entity/Q5225810"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/85/Darusentan.svg","width":512,"height":366}
fields total:
13
integrity:
15